Company Data
Longeveron Inc.
Ticker
LGVN
Current Price
$2.48 4.64%
Market Cap
$7.9M
Price Target
Refer to Report
Volume
58.4K
52wk Range
$2.3001 - $12.3
Overview
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).